Avantor (AVTR) Net Equity Issued and Repurchased (2017 - 2019)
Avantor's (AVTR) quarterly Net Equity Issued and Repurchased came in at -$100000.0 in Q3 2019, down 100.0% quarter-over-quarter from $3.0 billion in Q4 2017.
Avantor (AVTR) Net Equity Issued and Repurchased (2017 - 2019) Analysis & Trends
Avantor's Net Equity Issued and Repurchased history runs 2 years deep, the most recent figure standing at -$100000.0 for Q3 2019.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to -$100000.0 in Q3 2019; TTM through Dec 2020 was -$100000.0, a 0.0% change from a year earlier, with the FY2021 full-year figure at $967.0 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased declined to -$100000.0 in Q3 2019 per AVTR's latest filing, from $3.0 billion in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $3.0 billion in Q4 2017 and bottomed at -$100000.0 in Q3 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 7.43 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | - |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | - |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 11.72 Mn |
| 10 | Avantor | 7.67 Bn | 7.39 Bn | 500.70 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | -100,000.00 |
| Sep 30, 2019 | -100,000.00 |
| Dec 31, 2017 | 3.05 Bn |
| Dec 31, 2017 | 3.05 Bn |